NEW YORK (GenomeWeb News) – Bruker reported after the close of the market Thursday that its revenues in the first quarter were down 3 percent year over year, dropping to $393.4 million, compared to $405.6 million in Q1 2012.

The results fell short of the average Wall Street estimate of $417.0 million. Foreign currency effects were responsible for roughly half of that decline, the company said, with acquisitions and divestitures responsible for an additional net negative effect of a fraction of 1 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Nov
15
Sponsored by
Twist Bioscience

This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.